Katherine A Rantanen

Title: Katherine A Rantanen: Innovator in Pharmaceutical Crystallization

Introduction

Katherine A Rantanen is a prominent inventor based in Burlington, CA. She has made significant contributions to the field of pharmaceutical crystallization, holding a total of 4 patents. Her work focuses on developing novel crystalline forms of important pharmaceutical compounds.

Latest Patents

Among her latest patents, Katherine has developed crystalline forms of Ponatinib hydrochloride. This invention provides novel crystalline forms, including Ponatinib hydrochloride Form APO-I, APO-III, and APO-IV, which are obtained from acetonitrile/formic acid solutions. Additionally, Form APO-V is introduced, which is derived from concentrated hydrochloric acid. Another significant patent is for a novel crystalline form of Lumacaftor, specifically Lumacaftor Form APO-I, a co-crystal of Lumacaftor and nicotinamide, along with compositions and processes for its preparation.

Career Highlights

Katherine has established herself as a key figure in her field through her innovative research and development efforts. Her work has not only advanced the understanding of crystalline forms but has also contributed to the improvement of pharmaceutical formulations.

Collaborations

Katherine collaborates with talented professionals in her field, including Fabio E S Souza and Bahareh Khalili. These collaborations enhance the research and development process, leading to more effective pharmaceutical solutions.

Conclusion

Katherine A Rantanen's contributions to pharmaceutical crystallization exemplify her dedication to innovation in the field. Her patents reflect her commitment to advancing healthcare through scientific research and development.